INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
How Adept CMC Management Blazes A Trail To The Clinic
Properly executing CMC management — and CMC outsourcing, in particular — mitigates risk and provides opportunities to accelerate pharmaceutical developers’ rush to clinic. Making decisions within the context of a specific therapeutic area and molecular biology, as well as securing specialized partners, helps companies generate a more accurate gap and risk assessment.
-
Importance Of Assessing Mannitol Crystallinity In Lyophilized Drug Products
Drug product stability may be seriously compromised if mannitol completes crystallization during storage rather than during the freezing or annealing step in the lyophilization process.
-
Meeting Needs And Exceeding Expectations Worldwide
Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.
-
Setting The Standard For Plasmid DNA Production
Discover how Boehringer Ingelheim’s expertise in plasmid DNA manufacturing can propel your innovative therapies forward and transform patient care.
-
Simtra Brand Anthem Video
You can count on our extensive scientific and manufacturing expertise, stringent quality standards, and highly responsive customer service to ensure timely delivery of your life-changing products.
-
Support Of Scale-Up And Technical Transfer Through Understanding Equipment
See how our expertise in formulation and process development can ensure a seamless scale-up from laboratory to full-scale production of lyophilized injectable products.
-
Seasonal Vaccine Manufacturing
Explore how our contract manufacturing solutions can help you meet the growing demand for seasonal influenza vaccines efficiently and effectively.
-
Process Development For Lyophilized Products
Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
Best Practices In Formulation And Lyophilization Development: Proteins, mAbs And ADCs
Discover how advancements in pharmaceutical freeze-drying are reshaping the process through better product understanding, precise process control, and innovations in equipment efficiency.